ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads*
Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets.
We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you.
We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor.
Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide.
Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS:
👉a new group of investors that will sustain the completion of OUR PROJECT
👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision.
*May 28, 2014 http://doi.org/10.1093/brain/awu102.
Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets.
We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you.
We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor.
Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide.
Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS:
👉a new group of investors that will sustain the completion of OUR PROJECT
👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision.
*May 28, 2014 http://doi.org/10.1093/brain/awu102.
Location: Switzerland, Vaud, Lausanne
Employees: 51-200
Total raised: $57.24M
Founded date: 2013
Investors 3
| Date | Name | Website |
| 05.08.2024 | Venture Ki... | venturekic... |
| - | Mountain L... | mountainla... |
| - | VentureLab | venturelab... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 17.12.2019 | Series E | $8.14M | - |
| 03.10.2017 | Series D | $13M | - |
| 27.05.2016 | Series C | $18M | - |
| 10.04.2012 | Series B | $4.36M | - |
| 30.08.2011 | Series A | $13.75M | - |
Mentions in press and media 36
| Date | Title | Description |
| 20.09.2022 | CE-Mark for Aleva’s Deep Brain Stimulation | |
| 02.06.2022 | Sparks IPO Academy completes first edition with 13 companies | |
| 28.02.2022 | Aleva receives FDA approval to start US Study | |
| 09.07.2021 | Successful collaboration between Aleva Neurotherapeutics and DIXI Medical | Adept Neuro has exclusive intellectual property rights of Aleva Neurotherapeutics in the fields of epilepsy. DIXI Medical ensures the exclusive production and distribution of the Adept Neuro’s products, while DIXI Holding will finance the j... |
| 22.06.2021 | Aleva’s first Deep Brain Stimulation System implanted | Deep brain stimulation (DBS) is approved worldwide for the treatment of Parkinson’s disease (PD), essential tremor, dystonia, obsessive-compulsive disorder (OCD), and epilepsy. The approach relies on the delivery of mild electrical pulses t... |
| 22.06.2021 | Aleva’s first Deep Brain Stimulation System implanted | |
| 03.08.2020 | Three companies a step away from winning the Swiss Medtech Award | Every year, the Swiss Medtech Award honours the most outstanding medical technologies in Switzerland. From its shortlist of eleven start-ups, the selection committee has nominated three companies that will have the opportunity to present th... |
| 03.08.2020 | Three companies a step away from winning the Swiss Medtech Award | |
| 25.06.2020 | Swiss Medtech Award presents the shortlist | The Swiss Medtech Award recognises the most outstanding medical technologies in Switzerland. The jury has selected seven companies that will further compete for one of three spots of the final round and to get the chance to present their id... |
| 25.06.2020 | Swiss Medtech Award presents the shortlist |
Show more